The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score-Reference-Cited by-同舟云学术

The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score

Published:2017-03-13 Issue:9 Volume:19 Page:1084-1090
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Carmona-Bayonas A.^ORCID,Jiménez-Fonseca P.,Virizuela Echaburu J.,Sánchez Cánovas M.,Ayala de la Peña F.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s12094-017-1644-z/fulltext.html

Reference34 articles.

1. Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31:794–810.

2. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18:3038–51.

3. Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, et al. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2016;27:v111–8.

4. Hui EP, Leung LKS, Poon TCW, Mo F, Chan VTC, Ma ATW, et al. Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network. Support Care Cancer. 2011;19:1625–35.

5. Uys A, Rapoport BL, Anderson R. Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score. Support Care Cancer. 2004;12:555–60.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors;Life;2021-12-11

2. Risk-Stratifying Treatment Strategies for Febrile Neutropenia—Tools, Tools Everywhere, and Not a Single One That Works?;JCO Oncology Practice;2021-11

3. Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients;Gynecologic Oncology Reports;2021-08

4. The role of serum albumin/globulin ratio in combination with prognostic risk indexes of febrile neutropenia;International Journal of Clinical Practice;2021-04-05

5. CISNE versus MASCC: Identifying low risk febrile neutropenic patients;The American Journal of Emergency Medicine;2020-11